A dual-illumination positioning nasoenteric tube device
By using a dual-illumination positioning nasoenteric tube device, which combines an indwelling balloon and an imaging ring, the device achieves visualized positioning of the nasoenteric tube and stability of the catheter in the small intestine. This solves the problems of insertion error and poor delivery in existing technologies, and improves the safety and efficiency of catheter placement.
Patent Information
- Application Number
- CN202522023786.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2025-09-19
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2035-09-19
AI Technical Summary
Existing nasoenteric tube placement methods have several drawbacks, including the risk of the tube accidentally entering the trachea, difficulty in stably passing through the pylorus, inaccurate placement depth, lack of real-time visual guidance, and insufficient monitoring of the tube's morphology in the small intestine, all of which affect the delivery of nutrient solutions.
A dual-illumination positioning nasoenteric tube was designed, utilizing a combination of an indwelling balloon and an imaging ring. The insertion depth was limited by inflating the infusion balloon, and the visualization and positioning of the gastric and intestinal segments were achieved with the help of ultrasound guidance. Combined with precise guidance by a guidewire, the tube was ensured to be patency and fixed in position within the small intestine.
This improved the controllability and success rate of nasoenteric tube placement, ensured unobstructed nutrient delivery pathways, reduced the risk of aspiration and blockage, and enhanced the safety and efficiency of the placement procedure.
Smart Images

Figure CN224949331U_ABST
Abstract
Description
Technical Field
[0001] This utility model relates to the field of medical device technology, and in particular to a dual-illumination positioning nasoenteric tube device. Background Technology
[0002] For patients unable to safely eat orally due to prolonged coma, severe dysphagia, esophageal obstruction, or impaired gastric emptying (such as gastroparesis), enteral nutritional support is crucial. Nasojejunal tubes (NJTs) are a commonly used clinical solution. Their core purpose is to bypass the dysfunctional upper digestive tract and deliver nutrients and medications directly to the duodenum or the beginning of the jejunum. This method aims to avoid the risk of aspiration due to delayed gastric emptying or gastroparesis and ensure effective absorption of nutrients in the small intestine, thereby maintaining the patient's nutritional status, supporting tissue repair, and helping to promote the recovery of intestinal function.
[0003] Currently, the most widely used method for nasoenteric tube placement in clinical practice is the "blind placement method." This method typically involves inserting the nasoenteric tube into the gastrointestinal tract through the nasal cavity with the assistance of a guidewire. However, this procedure presents significant challenges: the catheter may accidentally enter the trachea during placement, causing coughing or even respiratory complications; more commonly, the catheter tip may struggle to stably pass through the pylorus into the target small intestine segment, often resulting in insufficient placement depth (residing in the stomach) or excessive depth (reaching the distal jejunum). These deviations directly lead to inaccurate delivery of nutritional solutions to the intended small intestine location, severely impacting the patient's nutritional intake.
[0004] CN219071343U proposes an improved solution: a cannula design is used, with a nasoenteric tube stabilizer to fix the external portion to reduce tube movement, and a water-filled balloon at the tip assists the catheter through the pylorus, while an integrated optical fiber within the guidewire is used for internal positioning. However, this solution has the following drawbacks: First, fiber optic positioning relies on specific light source equipment, making it impossible to guide catheter placement and imaging under bedside ultrasound in clinical use, resulting in a lack of real-time, intuitive visualization guidance for adjusting the placement depth; second, the water-filled balloon used to assist passage through the pylorus is withdrawn after placement, and the external fixation device can only prevent displacement of the external tube segment, but cannot effectively prevent the internal segment of the catheter from migrating to the distal small intestine due to continuous gastrointestinal peristalsis; furthermore, this solution only provides the position information of the catheter tip and cannot monitor the specific morphology of the catheter after entering the small intestine. If the catheter coils in the duodenum, it not only affects the patency of nutrient infusion but also increases the risk of displacement or blockage, leading to tube dysfunction.
[0005] Furthermore, on the one hand, there are differences in understanding among those skilled in the art; on the other hand, the applicant studied a large number of documents and patents when making this utility model, but due to space limitations, not all details and contents were listed in detail. However, this does not mean that this utility model does not have the features of these prior art. On the contrary, this utility model has all the features of the prior art, and the applicant reserves the right to add relevant prior art to the background art. Utility Model Content
[0006] To address the shortcomings of existing technologies, this invention provides a dual-contrast positioning nasoenteric tube device, comprising a nasoenteric tube that can be inserted through the nasal cavity, esophagus, and stomach, ultimately reaching the jejunum. The nasoenteric tube is equipped with an indwelling balloon, which serves as a dividing point, dividing the nasoenteric tube into a gastric inlet segment near the proximal end and an intestinal inlet segment near the distal end. The portion of the gastric inlet segment located outside the body is equipped with an infusion balloon that is in fluid communication with the indwelling balloon. When contrast agent is injected into the indwelling balloon through the infusion balloon, the infusion balloon expands to exceed the pylorus, thereby using physical obstruction to limit the insertion depth of the gastric inlet segment. The intestinal inlet segment has multiple contrast rings distributed along its axial direction, using the contrast rings and the contrast agent within the infusion balloon to determine the fixed position of the gastric inlet segment and its extension posture within the intestine.
[0007] This invention utilizes a fluid-connected design between the infusion balloon and the indwelling balloon. When the indwelling balloon is filled with contrast agent, it simultaneously triggers balloon expansion, forming a reliable barrier due to its physical characteristic of exceeding the pyloric size. This effectively limits the insertion depth of the gastric segment, avoiding the risk of tube displacement caused by over-insertion. Simultaneously, the synergistic imaging properties of the contrast agent within the indwelling balloon and the multiple imaging rings axially distributed within the intestinal segment allow medical personnel to guide the insertion with bedside ultrasound and simultaneously observe the fixed position of the gastric segment and its extension within the intestine. This achieves dual visualization and positioning of the gastric anchor point and the intestinal path during insertion. This dual imaging mechanism not only improves the controllability of insertion depth but also prevents tube twisting or folding by visually displaying the arrangement of the intestinal segment, thus ensuring the unobstructed delivery path of the nutrient solution and a high success rate for the insertion procedure. Furthermore, the increased weight of the distal gastric segment after contrast agent injection helps to position the indwelling balloon more smoothly at the pylorus.
[0008] Preferably, the distal end of the intestinal segment is equipped with a conical or olive-shaped gravity tip. The head of the gravity tip is rounded, and a through-hole communicating with the lumen of the intestinal segment is opened on the side wall. The conical or olive-shaped contour of the gravity tip, combined with the rounded head design, significantly reduces tissue friction resistance when passing through the pylorus and duodenal bends, avoiding mucosal abrasion. In addition, the through-hole on the side wall of the gravity tip communicates with the lumen of the nasoenteric tube, allowing the nutrient solution to be directly delivered to the target intestinal segment from the side of the gravity tip, avoiding the risk of blockage by intestinal wall adhesion of traditional tip outlets, and ensuring continuous and unobstructed nutrient delivery.
[0009] Preferably, the device includes a guidewire penetrating the nasoenteric tube and a handle connected to the proximal end of the guidewire. The distal end of the guidewire extends to a gravity-fed end. The handle is configured to change the shape of the guidewire by rotation, pushing, or retraction. This design, where the guidewire penetrates the nasoenteric tube and extends to the gravity-fed end, combined with the rotation, pushing, or retraction function of the proximal handle, allows medical personnel to dynamically adjust the curvature of the guidewire within the body. This precisely guides the gravity-fed end through the physiological curvature of the pylorus and duodenum, significantly improving the smoothness and path controllability of the intestinal segment insertion.
[0010] Preferably, the portion of the gastric inlet segment located outside the patient's body is connected to an infusion balloon via an infusion tube, allowing the infusion balloon to maintain fluid connection with the indwelling balloon through the infusion tube. This fluid communication mechanism between the infusion balloon and the indwelling balloon, established through the infusion tube, allows healthcare professionals to directly control the inflation status of the indwelling balloon externally without interrupting the nutritional delivery function of the nasoenteric tube's main lumen. Changes in the volume of the infusion balloon synchronously reflect the degree of inflation of the indwelling balloon, providing intuitive external operational feedback and ensuring the reliability of the physical barrier effect.
[0011] Preferably, the gastric segment's lumen comprises a parallel and independent main lumen and a secondary lumen. The main lumen is used to deliver nutrient solution or medication and communicates with the intestinal segment's lumen; the secondary lumen is connected to the infusion balloon via an infusion tube. This dual-lumen, independent, parallel design physically separates the functional pathways of the main and secondary lumens, completely separating nutrient solution delivery from contrast agent filling. This ensures physical anchoring of the stomach while maintaining uninterrupted enteral nutrient delivery, significantly improving treatment safety and operational efficiency.
[0012] Preferably, a port base is provided at the proximal end of the gastric inlet segment, and the end of the port base has an opening communicating with the main lumen. This opening serves as the sole path for the guidewire to enter and exit the main lumen, ensuring precise guidance of the tubing during placement. Furthermore, this opening directly connects to an external infusion device, allowing unobstructed delivery of nutrient solution through the main lumen to the intestinal inlet segment, simplifying the procedure.
[0013] Preferably, the port base is equipped with a cap for opening and closing the opening, and the cap has an injection port for connecting an external infusion device. This cap, through the physical isolation of the opening, prevents external contaminants from entering the main lumen through the opening when closed, ensuring a sterile environment inside the tubing. Simultaneously, the integrated injection port on the cap creates an independent infusion channel, allowing the external infusion device to continuously deliver nutrient solution or medication to the main lumen even when the opening is closed, achieving time-sharing reuse of the guidewire operation channel and nutrient delivery function. This design avoids the contamination risks associated with traditional opening and closing operations while ensuring the parallel independence of nutrient supply and tubing adjustment functions, significantly improving the safety and convenience of clinical operations.
[0014] Preferably, the gastric inlet segment is equipped with a nasal clamp, which has an abutment plane for contacting the nose. This nasal clamp, through its abutment plane's adaptive contact with the nasal skin, effectively disperses the local pressure generated by traditional point clamps, significantly reducing the risk of nasal pressure sores caused by long-term fixation. Simultaneously, the stable support surface provided by the abutment plane enhances the friction between the clamp and the nose, preventing axial displacement of the nasoenteric tube due to traction or changes in body position, ensuring a constant physical obstruction position of the indwelling balloon at the pylorus, thereby maintaining the stability of the intestinal segment's extension posture within the intestine.
[0015] Preferably, the guidewire is inserted through the lumen of both the main lumen and the intestinal segment to guide the passage of the gastric and intestinal segments by changing its shape. Real-time dynamic adjustment of the guidewire shape (such as bending angle or pushing depth) via the handle precisely guides the gastric and intestinal segments to adapt to changes in the physiological curvature of the gastrointestinal tract, preventing folding or angled sections of the tube in narrow areas and ensuring the straightness and controllability of the overall nasoenteric tube passage path.
[0016] Preferably, the distal end of the secondary cavity leads directly to the indwelling balloon. This direct connection between the distal end of the secondary cavity and the indwelling balloon creates a closed, unidirectional transport path for the contrast agent from the infusion balloon to the indwelling balloon, eliminating the risk of contrast agent retention or leakage in the intermediate stages. Attached Figure Description
[0017] Figure 1 This is a schematic diagram of the overall structure of a preferred dual-illumination positioning nasoenteric tube device according to this utility model; Figure 2 This is a perspective view of a preferred dual-illumination positioning nasoenteric tube device of this utility model inside the human body; Figure 3 This is a cross-sectional view of the internal cavity of the preferred nasoenteric tube entering the stomach and the intestinal cavity of the present invention; Figure 4 This is a schematic diagram of a preferred cap of this utility model.
[0018] List of reference numerals 100: Stomach entry segment; 110: Nasal clamp; 120: Port base; 121: Cap; 122: Opening; 130: Infusion balloon; 140: Infusion tubing; 150: Main lumen; 160: Secondary lumen; 200: Intestinal entry segment; 210: Gravity tip; 220: Contrast ring; 300: Indwelling balloon; 400: Guidewire; 410: Handle; 500: Nasal cavity; 600: Esophagus; 700: Stomach; 710: Pylorus; 800: Intestine. Detailed Implementation
[0019] The following is a detailed explanation with reference to the accompanying drawings.
[0020] Directional definition: refer to Figure 2 The end of the device located outside the patient's body is defined as the proximal end, and the end of the device located inside the patient's body is defined as the distal end.
[0021] This embodiment relates to a dual-illumination positioning nasoenteric tube device, such as... Figure 2 As shown, the main structure of the device is a flexible nasoenteric tube, which can be inserted from outside the patient through the nasal cavity 500, esophagus 600, and stomach 700, finally reaching the intestine 800, for delivering enteral nutrition to the patient. Figure 1 As shown, the nasoenteric tube has an inflatable indwelling balloon 300 on its wall. When the indwelling balloon 300 reaches the stomach 700 with the nasoenteric tube, it can be inflated by filling it with gas or liquid. The inflated indwelling balloon 300 can exceed the diameter of the pylorus 710, thereby limiting the further insertion depth of the nasoenteric tube by means of its physical barrier effect.
[0022] like Figure 1 As shown, the nasoenteric tube can be divided into a gastric inlet segment 100 and an intestinal inlet segment 200, with the indwelling balloon 300 on the tube wall as the dividing point. The gastric inlet segment 100 refers to the proximal portion passing through the patient's nasal cavity 500, esophagus 600, and stomach 700; the intestinal inlet segment 200 refers to the distal portion passing through the pylorus 710 and extending into the intestine 800. The portion of the gastric inlet segment 100 located outside the patient's body is connected to an infusion balloon 130 via an infusion tube 140. The infusion balloon 130 maintains a fluid connection with the indwelling balloon 300 via the infusion tube 140. Medical personnel can change the volume of the infusion balloon 130 by pressing or other means, allowing the gas or liquid stored in the infusion balloon 130 to enter the indwelling balloon 300 via the infusion tube 140. According to a preferred embodiment, the infusion balloon 130 can be filled with contrast agent into the indwelling balloon 300. This configuration allows the indwelling balloon 300 to not only physically block further insertion of the nasoenteric tube, but also to assist in determining the fixed position of the gastric segment 100 by utilizing the contrast agent's imaging properties under ultrasound equipment.
[0023] like Figure 1As shown, a gravity-operated end 210 is provided at the distal end of the intestinal segment 200. This gravity-operated end 210 is cone-shaped or olive-shaped with a smooth, rounded head, designed to avoid scratching the gastrointestinal mucosa during insertion into the patient (especially through narrow areas such as the pylorus 710 and intestinal 800). The cone shape also reduces intestinal peristalsis resistance, facilitating natural descent and providing guidance. The gravity-operated end 210 is designed to be 1-2 cm long to reduce the burden on the intestinal segment 200. Furthermore, the gravity-operated end 210 is made of high-density polyethylene (HDPE), utilizing its own weight to create a downward gravity gradient, assisting the intestinal segment 200 in its propulsion along the physiological curves of the intestine. According to a preferred embodiment, the sidewall of the gravity-operated end 210 also has a through-hole communicating with the lumen of the intestinal segment 200, allowing nutrient solution or medication from the nasoenteric tube to flow out and be directly delivered to the patient's intestinal 800.
[0024] like Figure 1 As shown, the intestinal segment 200 has multiple contrast rings 220 on its wall, which are preferably evenly distributed along the axial surface of the intestinal segment 200. The length of the intestinal segment 200 is designed with reference to the anatomical length of the duodenum (25-30 cm) to ensure that the nutrient solution or medication flowing from the gravity end 210 can directly reach the patient's jejunum. The spacing of the contrast rings 220 is adapted to the length of the intestinal segment 200, for example, one ring every 5-6 cm, which allows medical staff to judge the depth of the intestinal segment 200 into the intestine 800 by observing the relative positions of the contrast rings 220, avoiding insertion that is too deep or too shallow. During the insertion process, the intestinal segment 200, under the traction of its own weight, can overcome the resistance of the pyloric sphincter 710 and smoothly enter the intestine 800. Once the nasoenteric tube is in place, medical staff can utilize the imaging characteristics of these imaging rings 220 under ultrasound equipment, combined with the imaging positioning of the contrast agent in the indwelling balloon 300 in the stomach 700, to achieve dual imaging verification of the fixed point in the stomach and the intestinal path. By judging whether the imaging rings 220 form a continuous line segment in the ultrasound image, and referring to whether the preset length of the intestinal segment 200 matches the total length of the imaging point, medical staff can more accurately assess whether the intestinal segment 200 is curled or folded within the intestine 800.
[0025] Preferably, such as Figure 1As shown, the dual-illumination positioning nasoenteric tube device of this embodiment also includes a guidewire 400 and a handle 410 located at the proximal end of the guidewire 400. The guidewire 400 is a slender, flexible component that penetrates the lumen of the nasoenteric tube, extending distally to near the gravity end 210, and rigidly connected proximally to the handle 410. Its shape can be changed by rotating, pushing, or retracting the handle 410, providing support and directional guidance for the nasoenteric tube. Preferably, if the imaging ring 220 shows that the intestinal segment 200 is curled up via ultrasound, medical personnel can adjust the curvature of the guidewire 400 by rotating the handle 410, and enhance the support and traction force on the intestinal segment 200 by pushing it forward. Simultaneously, the downward force of the gravity end 210 helps to straighten the curled portion. If path adjustment is needed, the tension of the tube can be relaxed by retracting the guidewire 400, and the direction can be redirected by intestinal peristalsis to ensure that the intestinal segment 200 passes smoothly through the intestine.
[0026] like Figure 3 As shown, the nasoenteric tube's gastric inlet segment 100 has a dual-lumen structure, with the main lumen 150 and the secondary lumen 160 arranged in parallel (coaxially or side-by-side) and independently separated. The main lumen 150 is used to deliver nutrient solution or medication, with its proximal end connected to an external infusion device (e.g., a syringe) and its distal end communicating with the lumen of the intestinal segment 200 to ensure that the nutrient solution or medication enters the intestine 800. The secondary lumen 160 is a dedicated pathway, with its proximal end connected to an infusion balloon via an infusion tube 140 and its distal end directly connected to an indwelling balloon 300 for delivering contrast agent to inflate the indwelling balloon 300. A guidewire 400 passes through the main lumen 150, extending in the same direction as the gastric inlet segment 100. When adjusted via the proximal handle 410, the main lumen 150 can be guided according to the shape of the guidewire 400, while the secondary lumen 160 maintains a stable pathway due to its connection to the indwelling balloon 300.
[0027] like Figure 1 As shown, a port base 120 is disposed proximally at the inlet segment 100. The end of the port base 120 has an opening 122, which communicates with the main lumen 150 of the inlet segment 100 for insertion of the guidewire 400 and input of nutrient solution or medication. A cap 121 is connected to the port base 120 for opening and closing the opening 122. The design of the cap 121 allows the device to be adapted to both wide-mouth and narrow-mouth syringes. Specifically, as... Figure 4 As shown, when the cap 121 is removed from the opening 122, the guidewire 400 can be inserted into the nasoenteric tube through this opening 122 and moved under the control of its proximal handle 410, thereby guiding the nasoenteric tube along the correct path within the patient's body. Once the nasoenteric tube reaches the correct position under the guidance of the guidewire 400, an external infusion device (such as a wide-bore syringe) can deliver nutrient solution or medication into the nasoenteric tube through this opening 122. When the cap 121 covers the opening 122, an external infusion device (such as a narrow-bore syringe) can be connected to the pre-set injection port on the cap 121, similarly enabling the delivery of nutrient solution or medication into the nasoenteric tube.
[0028] like Figure 1 As shown, the gastric inlet segment 100 is equipped with a nasal clamp 110, which is clip-shaped and used to achieve a second layer of fixation of the device after the nasoenteric tube is inserted into the patient's body by clamping the gastric inlet segment 100 and abutting against the nose. The nasal clamp 110 has a wide abutment surface for contacting the nasal septum and / or nasal ala. Specifically, after the indwelling balloon 300 is filled with contrast agent and inflated at the pylorus 710 to restrict further insertion of the nasoenteric tube, the nasal clamp 110 can be placed at the point where the gastric inlet segment 100 exits the patient's nasal cavity 500. Through its abutment against the patient's nose, this design can reduce the frequent friction and compression of the pylorus 710 by the indwelling balloon 300 due to gastrointestinal peristalsis, thereby reducing the patient's discomfort. Preferably, medical tape can also be provided on the nose clamp 110 to keep the relative position of the nose clamp 110 and the nose fixed, thereby preventing the nasoenteric tube from being accidentally pulled out.
[0029] It should be noted that the specific embodiments described above are exemplary. Those skilled in the art can devise various solutions inspired by the disclosure of this utility model, and these solutions all fall within the scope of this utility model and its protection scope. Those skilled in the art should understand that this utility model specification and its drawings are illustrative and do not constitute a limitation on the claims. The protection scope of this utility model is defined by the claims and their equivalents. This utility model specification contains multiple concepts; phrases such as "preferredly" or "according to a preferred embodiment" indicate that the corresponding paragraph discloses an independent concept. The applicant reserves the right to file divisional applications based on each concept.
Claims
1. A dual-illumination positioning nasoenteric tube device, comprising a nasoenteric tube capable of being inserted through the nasal cavity (500), esophagus (600), and stomach (700) and ultimately reaching the intestine (800), characterized in that, The nasoenteric tube is equipped with an indwelling balloon (300). Using the indwelling balloon (300) as the dividing point, the nasoenteric tube is divided into a gastric inlet segment (100) near the proximal side and an intestinal inlet segment (200) near the distal side. The portion of the gastric inlet segment (100) located outside the body is provided with an infusion balloon (130) that is in fluid communication with the indwelling balloon (300). When contrast agent is injected into the indwelling balloon (300) through the infusion balloon (130), the infusion balloon (130) expands to exceed the pylorus (710), thereby using physical blocking to limit the insertion depth of the gastric inlet segment (100). The intestinal segment (200) has multiple imaging rings (220) distributed along its axis, so as to determine the fixed position of the stomach segment (100) and the extension posture of the intestinal segment (200) in the intestine (800) by means of the imaging characteristics of the imaging rings (220) and the contrast agent in the infusion balloon (130).
2. The apparatus according to claim 1, characterized in that, The distal end of the intestinal segment (200) is provided with a conical or olive-shaped gravity end (210), the head of which is rounded and the side wall is provided with a through hole communicating with the inner cavity of the intestinal segment (200).
3. The apparatus according to claim 2, characterized in that, The device includes a guidewire (400) extending through the nasoenteric tube and a handle (410) connected to the proximal end of the guidewire (400), the distal end of the guidewire (400) extending to the gravity end (210), wherein the handle (410) is configured to change the shape of the guidewire (400) by rotation, pushing or retraction.
4. The apparatus according to claim 3, characterized in that, The portion of the gastric inlet segment (100) located outside the patient's body is connected to the infusion balloon (130) via an infusion tube (140) so that the infusion balloon (130) is kept in fluid connection with the indwelling balloon (300) via the infusion tube (140).
5. The apparatus according to claim 4, characterized in that, The inner lumen of the gastric inlet segment (100) includes a main lumen (150) and a secondary lumen (160) arranged in parallel and independent of each other. The main lumen (150) is used to deliver nutrient solution or drugs and is connected to the inner lumen of the intestinal inlet segment (200). The secondary lumen (160) is connected to the infusion balloon (130) through an infusion tube (140).
6. The apparatus according to claim 5, characterized in that, The proximal end of the gastric inlet segment (100) is provided with a port base (120), and the end of the port base (120) is provided with an opening (122) communicating with the main cavity (150).
7. The apparatus according to claim 6, characterized in that, The port base (120) is provided with a cap (121) for opening and closing the opening (122), and the cap (121) is provided with an injection port for connecting an external infusion device.
8. The apparatus according to claim 1, characterized in that, The stomach section (100) is provided with a nose clamp (110) having an abutment plane for contacting the nose.
9. The apparatus according to claim 5, characterized in that, The guidewire (400) is disposed through the inner cavities of the main lumen (150) and the intestinal segment (200) to guide the passage path of the stomach segment (100) and the intestinal segment (200) by changing the shape of the guidewire (400).
10. The apparatus according to claim 5, characterized in that, The distal end of the secondary cavity (160) leads directly to the indwelling balloon (300).
